Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up.
Blood
; 136(18): 2027-2037, 2020 10 29.
Article
in En
| MEDLINE
| ID: mdl-32698195
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidines
/
Pyrazoles
/
Pyrimidines
/
Salvage Therapy
/
Waldenstrom Macroglobulinemia
/
Drug Resistance, Neoplasm
/
Neoplasm Recurrence, Local
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2020
Document type:
Article
Affiliation country:
Australia
Country of publication:
United States